Recent Patents on Anti-Infective Drug Discovery
Title:Patent Selections:
Volume: 7 Issue: 3
Export Options
About this article
Cite this article as:
Patent Selections:, Recent Patents on Anti-Infective Drug Discovery 2012; 7 (3) . https://dx.doi.org/10.2174/157489112803521940
DOI https://dx.doi.org/10.2174/157489112803521940 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
10
Related Articles
-
Phospholipase A2 Myotoxins from Bothrops Snake Venoms: Structure- Function Relationship
Current Organic Chemistry Nanodelivery Systems for Mucosal Vaccines
Recent Patents on Nanomedicine AKT and cytosolic phospholipase A<sub>2</sub>α form a positive loop in prostate cancer cells
Current Cancer Drug Targets Nanoemulsion: The Emerging Contrivance in the Field of Nanotechnology
Nanoscience & Nanotechnology-Asia Minocycline and Doxycycline: More Than Antibiotics
Current Molecular Pharmacology Targeting Proteasomes with Naturally Occurring Compounds in Cancer Treatment
Current Cancer Drug Targets Perivascular Adipose Tissue as an Endocrine Organ: The Role of Statins
Current Pharmaceutical Design Role of FAS in HIV Infection
Current HIV Research The Potential of Tetrandrine Against Gliomas
Anti-Cancer Agents in Medicinal Chemistry Clinical Features and Disease Damage Risk Factors in an Egyptian SLE Cohort: A Multicenter Study
Current Rheumatology Reviews Anti-inflammatory Properties of Lactic Acid Bacteria: Current Knowledge,Applications and Prospects
Anti-Infective Agents in Medicinal Chemistry Cyclotides, a Novel Ultrastable Polypeptide Scaffold for Drug Discovery
Current Pharmaceutical Design Erythropoietin in Stroke Therapy: Friend or Foe
Current Medicinal Chemistry Intraocular Immune Mechanisms in Uveitis
Current Immunology Reviews (Discontinued) Towards the Management of Inflammation: Recent Developments of mPGES-1 Inhibitors
Recent Patents on CNS Drug Discovery (Discontinued) Sunflower Trypsin Inhibitor 1 as a Molecular Scaffold for Drug Discovery
Current Pharmaceutical Design Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets
Current Drug Targets Pain and Child: A Translational Hypothesis on the Pathophysiology of a Mild Type-2 Diabetes Model
Endocrine, Metabolic & Immune Disorders - Drug Targets Peironimev-Plus® in the Treatment of Chronic Inflammation of Tunica Albuginea (Peyronie’s Disease). Results of a Controlled Study
Inflammation & Allergy - Drug Targets (Discontinued) Ketamine for Chronic Pain and Treatment Resistant Depression: A Mechanistic Hypothesis
Current Drug Therapy